Bortezomib Inpatient Prescribing Practices in Free-Standing Children's Hospitals in the United States

• Amanda M. DiNofia ,

  Contributed equally to this work with: Amanda M. DiNofia, Elizabeth Salazar

  * E-mail: dinofiaa@email.chop.edu

  Affiliation Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• Elizabeth Salazar ,

  Contributed equally to this work with: Amanda M. DiNofia, Elizabeth Salazar

  Affiliation Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• Alix E. Seif,

  Affiliations Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Yimei Li,

  Affiliations Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Yuan-Shung Vera Huang,

  Affiliation Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• Rochelle Bagatell,

  Affiliations Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America

  ⨯
• Brian T. Fisher,

  Affiliations Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America, Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, Division of Infectious Diseases, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯
• Richard Aplenc

  Affiliations Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America, Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America

  ⨯